logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12042514 B1

PDFFull Text
Date of Patent:
Jul. 23, 2024

Filed:

Mar. 16, 2023

Therapeutic material with low ph and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses

Applicant:

Tygrus, Llc, Troy, MI (US);

Inventors:

Paul Bundschuh, Austin, TX (US);

Lawrence Carlson, North Branch, MI (US);

Shawn Dolan, Sterling Heights, MI (US);

Andrew M. Yaksic, Brighton, MI (US);

Assignee:

Tygrus, LLC, Troy, MI (US);

Attorney:

Young Basile Hanlon & MacFarlane, P.C.

Primary Examiner:

Bethany P Barham

Assistant Examiner:

Peter Anthopolos

Int. Cl.
CPC ...
A61K 33/42 (2006.01); A61K 9/00 (2006.01); A61K 31/137 (2006.01); A61K 31/198 (2006.01); A61K 31/215 (2006.01); A61K 31/4045 (2006.01); A61K 31/405 (2006.01); A61K 31/4704 (2006.01); A61K 31/513 (2006.01); A61K 31/569 (2006.01); A61K 31/573 (2006.01); A61K 31/58 (2006.01); A61K 31/616 (2006.01); A61K 31/675 (2006.01); A61K 31/7056 (2006.01); A61K 31/7076 (2006.01); A61K 33/00 (2006.01); A61K 33/04 (2006.01); A61K 33/20 (2006.01); A61K 33/40 (2006.01); A61K 45/06 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 31/14 (2006.01); A61P 31/16 (2006.01);
U.S. Cl.
CPC ...
A61K 33/42 (2013.01); A61K 9/0078 (2013.01); A61K 31/137 (2013.01); A61K 31/198 (2013.01); A61K 31/215 (2013.01); A61K 31/4045 (2013.01); A61K 31/405 (2013.01); A61K 31/4704 (2013.01); A61K 31/513 (2013.01); A61K 31/569 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61K 31/616 (2013.01); A61K 31/675 (2013.01); A61K 31/7056 (2013.01); A61K 31/7076 (2013.01); A61K 33/00 (2013.01); A61K 33/04 (2013.01); A61K 33/20 (2013.01); A61K 33/40 (2013.01); A61K 45/06 (2013.01); A61P 31/04 (2018.01); A61P 31/10 (2018.01); A61P 31/14 (2018.01); A61P 31/16 (2018.01);
Abstract

Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.

Find Patent Forward Citations

Loading…